| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 47.665 | 37.554 | 46.094 | 44.963 | 53.033 | 50.695 | 38.851 | 63.299 | 72.148 | 82.074 |
| Total Income - EUR | 47.724 | 37.659 | 46.096 | 44.964 | 53.033 | 50.759 | 39.149 | 63.300 | 72.148 | 82.074 |
| Total Expenses - EUR | 32.061 | 18.087 | 26.565 | 25.112 | 31.502 | 25.323 | 21.337 | 18.616 | 24.172 | 22.733 |
| Gross Profit/Loss - EUR | 15.663 | 19.571 | 19.530 | 19.852 | 21.531 | 25.437 | 17.811 | 44.685 | 47.976 | 59.341 |
| Net Profit/Loss - EUR | 14.233 | 19.196 | 19.069 | 19.402 | 21.000 | 25.087 | 17.423 | 44.052 | 47.255 | 56.879 |
| Employees | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Derma Nova Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.334 | 4.150 | 3.943 | 3.837 | 3.763 | 5.718 | 5.274 | 4.973 | 7.745 | 7.289 |
| Current Assets | 37.570 | 39.584 | 39.254 | 36.554 | 38.963 | 38.548 | 29.176 | 57.631 | 52.543 | 56.541 |
| Inventories | 1.700 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 8.634 | 1.591 | 916 | 5.606 | 5.969 | 6.061 | 1.566 | 6.320 | 5.113 | 8.833 |
| Cash | 27.236 | 37.993 | 38.339 | 30.948 | 32.994 | 32.487 | 27.610 | 51.311 | 47.430 | 47.708 |
| Shareholders Funds | 14.938 | 19.886 | 19.795 | 20.114 | 21.698 | 25.772 | 18.093 | 44.724 | 49.067 | 58.682 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 23.790 | 24.962 | 24.497 | 21.351 | 24.295 | 18.866 | 16.721 | 18.245 | 11.221 | 5.147 |
| Income in Advance | 4.301 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Derma Nova Med S.r.l.